Actinium Pharmaceuticals, Inc. (ATNM)
Cost of Revenue
-$395.00K
TTM · Period ending: · USD
ATNM Cost of Revenue
Latest reported-$395.00Kperiod ending
Latest reported-$395.00Kperiod ending
ATNM TTM Cost of Revenue ($0.00 → -$395.00K)
TTM cost of revenue
High-resolution chart · PNG
ATNM cost of revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Cost of Revenue (USD) |
|---|---|
| -395,000 | |
| -395,000 | |
| -615,000 | |
| 204,000 | |
| 406,000 | |
| 595,000 | |
| 811,000 | |
| 806,000 | |
| 804,000 | |
| 824,000 | |
| 608,000 | |
| 570,000 | |
| 591,000 | |
| 562,000 | |
| 699,000 | |
| 675,000 | |
| 454,000 | |
| 274,000 | |
| 137,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 104,361 | |
| 104,361 | |
| 104,361 | |
| 104,361 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |